RIPK3 and metabolic dysfunction-associated steatotic liver disease: In diet-induced MASLD models, the absence of MLKL consistently reduces liver inflammation [21, 24, 45], while outcomes for Ripk3−/− mice vary depending on the dietary composition [13, 24, 46].